v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Revenue:        
Gross Sales     $ 0 $ 0
Cost of Sales     0 0
Gross Margin     0 0
Operating Expenses:        
Professional fees $ 62,913 $ 151,120 343,498 131,054
General and administrative 173,843 218,648 993,291 1,051,798
Consulting 176,534 515,189 1,779,681 1,666,553
Total operating expenses 413,290 884,957 3,116,470 2,849,405
Loss from continuing operations (413,290) (884,957) (3,116,470) (2,849,405)
Other Income (Expense):        
Change in fair value of derivatives (366,009) (202,710) (179,252) 161,122
Change in fair value of contingent liability 174,675 15,000 (47,500) (437,500)
Loss on issuance of derivatives (1,086,158) (17,676) (2,068,536) (191,162)
Loss on impairment of assets     (579,957) (957,377)
Unrealized loss on investment in WTXR     (147,435) 0
Gain on extinguishment of derivative liability 28,573 351,971 1,431,541 264,539
Amortization of intangible assets     0 (112,850)
Interest income 3,366 3,288 12,564 10,768
Interest expense (402,897) (331,723) (1,464,963) (759,013)
Total other expense, net (1,648,450) (181,850) (3,043,538) (2,021,473)
Loss from continuing operations (2,061,740) (1,066,807) (6,160,008) (4,870,878)
Discontinued Operations:        
Loss from operations of discontinued operations 0 (81,274) (1,462,514) (1,495,106)
Loss from shutdown of Axenic     (18,451) 0
Total Discontinued Operations 0 (81,274) (1,480,965) (1,495,106)
Net loss before income taxes (2,061,740) (1,148,081) (7,640,973) (6,365,984)
Provision for income taxes 0 0 0 0
Net Loss (2,061,740) (1,148,081) (7,640,973) (6,365,984)
Net loss attributable:        
Non-controlling interest 0 (4,530) (89,057) (12,815)
Common stockholders (2,061,740) (1,143,551) (7,551,916) (6,353,169)
Net loss $ (2,061,740) $ (1,148,081) $ (7,640,973) $ (6,365,984)
Loss per share, basic $ (0.01) $ (0.01) $ (0.07) $ (0.07)
Loss per share, diluted $ (0.01) $ (0.01) $ (0.07) $ (0.07)
Weighted average shares outstanding, basic 155,230,324 110,756,892 115,064,908 92,515,600
Weighted average shares outstanding, diluted 155,230,324 110,756,892 115,064,908 92,515,600